Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 217 of 6351
-
Can a psychedelic compound ease suicidal thoughts in bipolar depression?
Symptom relief Recruiting nowThe purpose of the study is to assess the safety and acceptability of up to two sequential administrations of 25 mg psilocybin with additional therapeutic support in decreasing suicidality in patients with Bipolar Disorder (BD II) depression.
Phase 2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Nature's shield for the aging brain? plant compound tested against vascular cognitive decline
Disease control Recruiting nowThe purpose of this clinical trial is to understand and evaluate the clinical efficacy and safety of Daphnetin Capsule in patients with vascular cognitive impairment. Changes in the Vascular Dementia Assessment Scale-cog(VADAS-cog) at 6 months were evaluated. Although Daphnetin h…
Sponsor: First People's Hospital of Shenyang • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could starting feeds sooner shield preterm babies from infection?
Disease control Recruiting nowStudy Hypothesis/Question In infants born very preterm, advancing enteral feeds after 24 hours from birth (limited trophic feeds) versus after 72 hours (extended trophic feeds) reduces the risk of all-cause late onset sepsis (LOS) without increasing the risk of other adverse outc…
Phase 2/3 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
A gentler brain zap may unlock stronger arm recovery after stroke
Disease control Recruiting nowObjectives: To compare the effects of low intensity priming intermittent theta burst stimulation (iTBS) with those derived from conventional intensity priming iTBS, nonpriming iTBS, and sham stimulation in terms of improving hemiparetic upper limb motor functionality and modulati…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New radioactive cocktail aims to shrink tough prostate tumors
Disease control Recruiting nowThe purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA817), given for up to 6 cycles at a dose of 10 Megabecquerel (MBq) +/- 10%, plus androgen receptor pathway inhibitor (ARPI), improves the radiographic progression free survival (rPFS) compared to investiga…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a higher aspirin dose stop preterm births? large trial launches
Prevention Recruiting nowThis is a phase-III multi-center double-blind randomized clinical trial of 1,800 individuals with a history of prior preterm birth at less than 35 weeks gestation who are randomized to either 162 mg aspirin or 81 mg aspirin daily. The study drug will be initiated between 10 and 1…
Phase 3 • Sponsor: The George Washington University Biostatistics Center • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
New combo aims to stop ovarian Cancer's return
Disease control Recruiting nowThis is a randomized trial evaluating the results of using of PARP inhibitor combined with angiogenesis inhibitor. in patients with homologous recombination deficient primary ovarian cancer, fallopian-tube cancer, or primary peritoneal cancer of the III-IV stages.
Phase 2/3 • Sponsor: N.N. Alexandrov National Cancer Centre • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can robots make hernia surgery safer and faster?
Disease control CancelledIn the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard. To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation t…
Sponsor: Algemeen Ziekenhuis Maria Middelares • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can adding immunotherapy boost a stomach cancer combo?
Disease control Recruiting nowThis study is a prospective, randomized, non-controlled, open-label clinical trial aimed at evaluating the efficacy and safety of adebrelimab combined with apatinib mesylate and albumin-bound paclitaxel, as well as apatinib mesylate combined with albumin-bound paclitaxel, in trea…
Phase 2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
A new approach to curb binge eating may lower diabetes risk in young black women
Prevention OngoingBlack Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), whic…
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Slowing down immunotherapy infusion may reduce pain in children with Tough-to-Treat neuroblastoma
Disease control Recruiting nowThis research is being done to investigate a treatment regimen of Irinotecan, Temozolomide, and Sargramostin, and an immunotherapy called Naxitamab and whether giving Naxitamab more slowly reduces the side effects for participants with relapsed or refractory neuroblastoma. The n…
Phase 1 • Sponsor: Steven DuBois, MD • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can a targeted biopsy replace full neck surgery for High-Risk skin cancer?
Disease control CancelledThis is a phase 2 pragmatic study at a single site that evaluates the clinical benefit of SLNB in patients with high-risk cSCC and cN0. The primary goal is to evaluate the efficacy of SLNB based on the DFS rate at 2 years post-definitive therapy.
Phase 2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a stomach tuck reverse fatty liver?
Disease control Recruiting nowMetabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the standard treatment, most patients regain weight limiting ultimate improvement in liver disease. On the other…
Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail aims to outsmart resistant breast cancer
Disease control Recruiting nowThis is an open-label, single-center, exploratory, Phase Ib/II clinical trial evaluating the safety and efficacy of entinostat combined with pyrotinib and endocrine therapy in patients with advanced hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-posi…
Phase 1/2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New cream could ease painful skin bumps for HS patients
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Cutting scans, keeping safety: a new streamlined approach to liver cancer treatment
Disease control Recruiting nowTARE uses radioactive microspheres (20-60 μm), which are trapped in tumors due to abnormal vasculature, while normal liver sinusoids (≤15 μm) prevent their passage. However, some microspheres may drain into hepatic veins and reach the lungs, risking radiation pneumonitis. Pre-pro…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could a common heart drug boost ovarian cancer treatment?
Disease control Recruiting nowOvarian Cancer (OC) is one of the most common gynecological malignant tumors. In recent years, the incidence of ovarian cancer in China has been on the rise, but its mortality ranks the first among gynecological tumors. Cytoreductive Surgery (CRS) combined with chemotherapy is th…
Phase 2 • Sponsor: Bai-Rong Xia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could this drug help patients with Hard-to-Treat breast cancer?
Disease control Recruiting nowThe purpose of this study is to test the good and bad effects of a drug called trastuzumab deruxtecan (T-DXd) in adult patients with metastatic HER2-negative breast cancer and which patients might benefit the most from T-DXd.
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a targeted pill keep leukemia from returning after transplant?
Disease control Recruiting nowmaintenance of AML or MDS patients with known IDH1 mutation after allogeneic stem cell transplantation within past 100 days
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can an immunotherapy combo shrink sinonasal tumors before surgery?
Disease control Recruiting nowThe aim of this research study is to evaluate the effectiveness and safety of a combination of immunotherapy, using a drug called toripalimab, with chemotherapy drugs, Carboplatin and Docetaxel, as a possible treatment before surgery for sinonasal cancers. The names of the study…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC